Psoriasis Clinical Trials

Showing 841-860 of 888 trials

A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris

NCT00277225

The purpose of this protocol is to determine the single-dose pharmacokinetics and immunogicity of BMS-188667 administered as a 1 hour intravenous infusion with extended pharmacokinetic sampling. Safety of all subjects will be assessed in a double blind fashion through the inclusion of placebo controls at each dose level.

Psoriasis Vulgaris

Bristol-Myers Squibb32 participantsStarted Nov 1995

Beverly Hills, California, United States

COMPLETEDPhase 3

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722

The objective of this study was to evaluate the safety and efficacy profile of Humira (adalimumab) in patients who had a sub-optimal response to prior systemic therapy. This open-label study was conducted in a patient population of moderate to severe chronic plaque psoriasis patients, which is an approved patient population for adalimumab.

Psoriasis

Abbott152 participantsStarted Jan 2008

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • San Diego, California, United States +22 more locations

A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Related Searches

A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis

Adalimumab in Adult Japanese Subjects With Psoriasis

Safety and Efficacy of BFH772 in Psoriasis Patients

Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis

Fluphenazine Decanoate for Psoriasis

BTT1023 in Psoriasis

Study Evaluating the Safety of Enbrel (Etanercept)

Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis

An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris

Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail Psoriasis

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis